Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Pharmaids Pharmaceuticals Ltd. shows significant underperformance across key financial metrics compared to its peers, with negative earnings and low efficiency ratios. The company is financially weak with high losses, low profitability, and low growth compared to industry leaders. It is positioned as a significant underperformer in the pharmaceutical sector.
Strong profitability with a PE ratio of 23.73 and an impressive EPS growth of 66.76.
High ROE and ROA with solid profitability metrics, ranking well in terms of financial health.
Exceptional revenue growth and solid profitability metrics, indicating strong market performance.